Deccan Health Care Ltd (DECCAN) — shareholding pattern, promoter holding, financials and share price
About Deccan Health Care Ltd (DECCAN)
Deccan Health Care Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as DECCAN and on the BSE under scrip code 542248. Its ISIN is INE452W01019.
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products [1]
Deccan Health Care Limited specializes in developing, manufacturing, and marketing nutraceutical, cosmeceutical, and ayurveda products. The company has shown impressive year-on-year revenue growth, driven by product diversification and market expansion in digital and retail sectors.
With a strong presence in functional foods, Deccan Health Care capitalizes on the growing demand for health-centric products by focusing on science-backed formulations and engaging consumer wellness programs.
Listed peers in Healthcare Service Provider: Bandaram Pharma Packtech Ltd, N G Industries Ltd, Sharma East India Hosp and Medical Research Ltd, Samsrita Labs Ltd, Tejnaksh Healthcare Ltd, Chennai Meenakshi Multispeciality Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹13.39 a share on 10 Jul 2026, Deccan Health Care Ltd (DECCAN) was valued at a price-to-earnings ratio of 12.65x against an industry P/E of 61.73x and a price-to-book of 0.29x on a book value of ₹45.42 per share as of Mar 2025. Solomo computes return on equity of 2.33% and return on capital employed of 3.38% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 12.65x
- Industry P/E
- 61.73x
- P/B
- 0.29x
- EPS (TTM)
- ₹1.06
- Book value / share
- ₹45.42
- ROE
- 2.33%
- ROCE
- 3.38%
- ROA
- 1.99%
- Debt / equity
- 0.01x
- Dividend yield
- 0%
- EBITDA margin
- 6.23%
- 52-week range
- ₹6.65 – ₹22.99
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Deccan Health Care Ltd (DECCAN) reported revenue of ₹81.9 crore, net profit of ₹2.49 crore and earnings per share of ₹1.01. That compares with revenue of ₹75.06 crore and net profit of ₹1.16 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹20.98 crore and net profit ₹0.33 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 33.17 | 45.02 | 59.73 | 75.06 | 81.9 |
| Net profit (₹ cr) | 0.32 | 0.31 | 1.49 | 1.16 | 2.49 |
| EPS (₹) | 0.2 | 0.18 | 0.73 | 0.5 | 1.01 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 21.75% | 12.20% | 31.33% | 25.67% |
| Profit growth | -14.80% | -34.70% | 54.60% | -22.15% |
| Stock price CAGR | - | -15% | -22% | -40% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 19.46% of Deccan Health Care Ltd (DECCAN) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 5.68%. Market capitalisation was ₹31 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2019.
Largest disclosed public shareholders in Jun 2026: FOCAL VENTURES PRIVATE LIMITED 9.69%, KOLLA UMANJA VENKATA SATYA SIVA SRIHARI 6.65%, VENTURE GURUKOOL INVESTMENT TRUST 5.68%, PATNI RAKESH . 4.73%, VIKRAM SHARAD SHETH 3.02%, HUF 3.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 19.46% | - | - | 5.68% | 80.54% |
| Mar 2026 | 19.46% | - | - | 5.68% | 80.54% |
| Dec 2025 | 18.42% | - | - | 5.37% | 81.58% |
| Sep 2025 | 18.42% | - | - | 5.37% | 81.58% |
| Jun 2025 | 18.42% | - | - | 5.37% | 81.58% |
| Mar 2025 | 19.46% | - | - | 5.68% | 80.54% |
| Dec 2024 | 18.26% | - | - | 5.87% | 81.74% |
| Sep 2024 | 15.66% | - | - | 6.34% | 84.34% |